Clinical Trials & Latest Studies Lead To Developments Indicating Cannabinoids

Today’s leading companies with recent developments of interest are Cannabis Science, Inc. (OTC: CBIS), Compass Diversified Holdings (NYSE: CODI ), NEMUS Bioscience, Inc. (OTC: NMUS), GW Pharmaceuticals (NASDAQ: GWPH ) and Insys Therapeutics, Inc. (NASDAQ: INSY ) Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing... more →
Posted in: Investing

Developments Indicating Cannabinoids Shown In Latest Studies And Clinical Trials

        After ImmunoClin successfully completed its one-year formulation work for CBIS, focusing on cannabis extracts and cannabinoids, the results are compelling and conclusive. ImmunoClin will, under its class I license, initiate, manage, and coordinate all aspects of the new comprehensive clinical research... more →
Posted in: News